Literature DB >> 16908749

Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia.

John Graff-Radford1, Kelly D Foote, Ramon L Rodriguez, Hubert H Fernandez, Robert A Hauser, Atchar Sudhyadhom, Christian A Rosado, Justin C Sanchez, Michael S Okun.   

Abstract

BACKGROUND: Dyskinesias that occur during a period without medication after embryonic cell transplantation have been commonly reported in double-blind trials; however, to date, they have not been reported in the few patients who participated in open-label pilot studies.
DESIGN: Single case observation with preoperative and postoperative data, and intraoperative single-cell physiology. PATIENT: A patient who underwent embryonic cell transplantation in 1993 as part of the University of South Florida open-label study was referred for evaluation of intractable dyskinesia of the right arm. The dyskinesia was present during evaluation of the patient after a 12-hour period without medication and was clinically disabling. It was manifested as a severe groping movement of the hand. Intraoperative physiologic evaluation revealed decreased firing rates in the internal segment of the globus pallidus.
RESULTS: Deep brain stimulation of the internal segment of the globus pallidus resulted in resolution of the dyskinesia.
CONCLUSION: This case highlights the delayed development of runaway dyskinesia after a period without medication as an important potential long-term adverse effect of embryonic cell transplantation in patients with Parkinson disease.

Entities:  

Mesh:

Year:  2006        PMID: 16908749     DOI: 10.1001/archneur.63.8.1181

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

Review 1.  Cell therapeutics in Parkinson's disease.

Authors:  Olle Lindvall; Anders Björklund
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 2.  Treatment of Parkinson's disease using cell transplantation.

Authors:  Olle Lindvall
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

Review 3.  Cell-based therapies for Parkinson disease—past insights and future potential.

Authors:  Roger A Barker; Janelle Drouin-Ouellet; Malin Parmar
Journal:  Nat Rev Neurol       Date:  2015-08-04       Impact factor: 42.937

4.  Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.

Authors:  Zinovia Kefalopoulou; Marios Politis; Paola Piccini; Niccolo Mencacci; Kailash Bhatia; Marjan Jahanshahi; Håkan Widner; Stig Rehncrona; Patrik Brundin; Anders Björklund; Olle Lindvall; Patricia Limousin; Niall Quinn; Thomas Foltynie
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.